MitoGenetics LLC
Rejuvenating mitochondria to treat diabetes
This article was originally published in Start Up
Executive Summary
Anyone who has ever taken a high-school science class has almost certainly been introduced to mitochondria as “the powerhouse of the cell, where energy is produced in the form of ATP.” MitoGenetics LLC believes it has identified a substance that can potentially fix things that start to break down in mitochondria as human cells age, and thereby restore normal cell function to reverse, or possibly even prevent, a great many diseases.
You may also be interested in...
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.
RxMP Therapeutics LLC
RxMP Therapeutics LLC is working to resolve excessive diffuse bleeding that is often associated with trauma, and also with certain orthopedic and cardiovascular surgeries. The start-up believes it can successfully treat excessive diffuse bleeding with particles produced from the membranes of red blood cells that have been freeze-dried and then, literally, blown to bits.